# Bristol-Myers Squibb (Germany)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/bristol-myers-squibb-germany/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 51 |
| Citations | 1,524,913 |
| City | Munich |
| Country | DE |
| Description | Bristol-Myers Squibb (Germany) is a research organisation in Munich, DE. OpenAlex records 8,982 works and 1,524,913 citations for it. 3,239 researchers list it as their most recent affiliation. |
| Homepage | http://www.b-ms.de/Pages/Home.aspx |
| OpenAlex ID | https://openalex.org/I157075465 |
| Researchers | 3,239 |
| ROR ID | https://ror.org/032hfv632 |
| Type | company |
| Wikidata ID | https://www.wikidata.org/wiki/Q266423 |
| Works | 8,982 |

## University collaborators

- [Bristol-Myers Squibb (United States)](https://scholariq.org/institutions/bristol-myers-squibb-united-states/)
- [Johns Hopkins University](https://scholariq.org/institutions/johns-hopkins-university/)

## University papers

Showing 12 of 17.

- [Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer](https://scholariq.org/papers/safety-activity-and-immune-correlates-of-anti-pd-1-antibody-in-cancer/)
- [Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer](https://scholariq.org/papers/safety-and-activity-of-anti-pd-l1-antibody-in-patients-with-advanced-cancer/)
- [Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates](https://scholariq.org/papers/phase-i-study-of-single-agent-anti-programmed-death-1-mdx-1106-in-refractory/)
- [Genetics of rheumatoid arthritis contributes to biology and drug discovery](https://scholariq.org/papers/genetics-of-rheumatoid-arthritis-contributes-to-biology-and-drug-discovery/)
- [Genomic atlas of the human plasma proteome](https://scholariq.org/papers/genomic-atlas-of-the-human-plasma-proteome/)
- [Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease](https://scholariq.org/papers/large-scale-meta-analysis-of-genome-wide-association-data-identifies-six-new/)
- [Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape](https://scholariq.org/papers/immune-inhibitory-molecules-lag-3-and-pd-1-synergistically-regulate-t-cell/)
- [Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci](https://scholariq.org/papers/genome-wide-association-study-meta-analysis-identifies-seven-new-rheumatoid/)
- [<i>STAT4</i> and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus](https://scholariq.org/papers/i-stat4-i-and-the-risk-of-rheumatoid-arthritis-and-systemic-lupus-erythematosus/)
- [Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis](https://scholariq.org/papers/five-amino-acids-in-three-hla-proteins-explain-most-of-the-association-between/)
- [Genome-wide Analyses Identify KIF5A as a Novel ALS Gene](https://scholariq.org/papers/genome-wide-analyses-identify-kif5a-as-a-novel-als-gene/)
- [Common variants at CD40 and other loci confer risk of rheumatoid arthritis](https://scholariq.org/papers/common-variants-at-cd40-and-other-loci-confer-risk-of-rheumatoid-arthritis/)

## University top topics

Showing 8 of 25.

- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Protein purification and stability](https://scholariq.org/topics/protein-purification-and-stability/)
- [HIV/AIDS drug development and treatment](https://scholariq.org/topics/hiv-aids-drug-development-and-treatment/)
- [Analytical Chemistry and Chromatography](https://scholariq.org/topics/analytical-chemistry-and-chromatography/)
- [Pharmacogenetics and Drug Metabolism](https://scholariq.org/topics/pharmacogenetics-and-drug-metabolism/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Drug Transport and Resistance Mechanisms](https://scholariq.org/topics/drug-transport-and-resistance-mechanisms/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.